Intranasal Civamide for Episodic Cluster Headache

• Status: Completed
• Trial end date: 2004-01-01

Summary

This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).

• Phase: Phase 3

Details

• Lead Sponsor: Winston Laboratories
• Treatments: Capsaicin; Pharmaceutical Solutions